Lon S. Schneider, MD, MS

Affiliations: 
Psychiatry and the Behavioral Sciences and Neurology University of Southern California, Los Angeles, CA, United States 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=125
Website:
http://www.usc.edu/uscnews/experts/945.html
Google:
"Lon Schneider"
Bio:

http://www.insidermedicine.com/archives/In_the_Spotlight_-_Dr_Lon_Schneider_MD_2687.aspx

http://www.alzforum.org/com/res/detail.asp?id={E6787F54-6A48-4124-8151-93EE69EF470F}

http://cadc.ucsf.edu/cadc/centers/leadership/lschneider

Mean distance: 21.34
 
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schneider LS, Hernandez G, Zhao L, et al. (2019) Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial. Menopause (New York, N.Y.)
Lee E, Gatz M, Tseng C, et al. (2019) Evaluation of Medicare Claims Data as a Tool to Identify Dementia. Journal of Alzheimer's Disease : Jad. 67: 769-778
Nation DA, Sweeney MD, Montagne A, et al. (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nature Medicine
Klinger RY, James OG, Borges-Neto S, et al. (2018) 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology
Sims R, van der Lee SJ, Naj AC, et al. (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics
Yassine HN, Rawat V, Mack WJ, et al. (2016) The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease. Alzheimer's Research & Therapy. 8: 25
Bang J, Lobach IV, Lang AE, et al. (2016) Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials. Parkinsonism & Related Disorders
Yesavage JA, Taylor JL, Friedman L, et al. (2016) Principal components analysis of agitation outcomes in Alzheimer's disease. Journal of Psychiatric Research. 79: 4-7
Leonpacher AK, Peters ME, Drye LT, et al. (2016) Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study. The American Journal of Psychiatry. appiajp201615020248
Dubois B, Hampel H, Feldman HH, et al. (2016) Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 12: 292-323
See more...